Product How it works Pricing Blog FAQ About Contact
Madrigal Pharmaceuticals

Madrigal Pharmaceuticals (NASDAQ: MDGL) revenue

Madrigal Pharmaceuticals reported revenue of $958.4m for fiscal 2025, 432.1% more than in fiscal 2024 ($180.1m).

Fiscal 2025 is the highest of the 9 fiscal years on record for Madrigal Pharmaceuticals.

Revenue, in millions of US dollars0.020170.020180.020190.020200.020210.020220.02023180.12024958.42025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$958.4m+432.1%−$300.1m−31.3%
2024$180.1m—−$497.9m−276.4%
2023$0.0m—−$380.5m—
2022$0.0m—−$293.6m—
2021$0.0m—−$242.5m—
2020$0.0m—−$206.7m—
2019$0.0m—−$95.0m—
2018$0.0m—−$40.7m—
2017$0.0m—−$32.1m—

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Madrigal Pharmaceuticals revenue compared with its sector

By revenue for its latest fiscal year, Madrigal Pharmaceuticals ranks 152nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Madrigal Pharmaceuticals, 432.1%.

RankCompanyRevenueRevenue growth
150thGuardant Health$982.0m32.9%
151stClaritev$965.4m3.7%
152ndMadrigal Pharmaceuticals$958.4m432.1%
153rdPennant Group$947.7m36.3%
154thIonis Pharmaceuticals$943.7m33.8%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Madrigal Pharmaceuticals

How much revenue did Madrigal Pharmaceuticals make in fiscal 2025?
Madrigal Pharmaceuticals reported revenue of $958.4m for fiscal 2025, compared with $180.1m in fiscal 2024.
What was the best year for revenue at Madrigal Pharmaceuticals?
Of its last 9 fiscal years, fiscal 2025, with $958.4m.
Where does Madrigal Pharmaceuticals rank in its sector by revenue?
It ranks 152nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Madrigal Pharmaceuticals come from?
From the annual report (Form 10-K) that Madrigal Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Madrigal Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Madrigal Pharmaceuticals: the Madrigal Pharmaceuticals page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.